Compounds > homonojirimycin
Page last updated: 2024-09-04

homonojirimycin and 4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide

homonojirimycin has been researched along with 4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide in 1 studies

Compound Research Comparison

Studies
(homonojirimycin)		Trials
(homonojirimycin)		Recent Studies (post-2010)
(homonojirimycin)		Studies
(4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide)		Trials
(4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide)		Recent Studies (post-2010) (4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide)
1507802

Protein Interaction Comparison

ProteinTaxonomyhomonojirimycin (IC50)4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide (IC50)
Lysosomal acid glucosylceramidaseHomo sapiens (human)0.601

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA1

Reviews

1 review(s) available for homonojirimycin and 4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide

ArticleYear
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
    Journal of medicinal chemistry, 2013, Apr-11, Volume: 56, Issue:7

    Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship

2013